Global and China Fragment-based Drug Discovery Market Size, Status and Forecast 2021-2027
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Fragment-based Drug Discovery Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Fragment Screening
1.2.3 Fragment Optimization
1.3 Market by Application
1.3.1 Global Fragment-based Drug Discovery Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Academic and Research Institutions
1.3.3 Biopharmaceutical Companies
1.3.4 Contract Research Organizations (CROs)
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Fragment-based Drug Discovery Market Perspective (2016-2027)
2.2 Fragment-based Drug Discovery Growth Trends by Regions
2.2.1 Fragment-based Drug Discovery Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Fragment-based Drug Discovery Historic Market Share by Regions (2016-2021)
2.2.3 Fragment-based Drug Discovery Forecasted Market Size by Regions (2022-2027)
2.3 Fragment-based Drug Discovery Industry Dynamic
2.3.1 Fragment-based Drug Discovery Market Trends
2.3.2 Fragment-based Drug Discovery Market Drivers
2.3.3 Fragment-based Drug Discovery Market Challenges
2.3.4 Fragment-based Drug Discovery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Fragment-based Drug Discovery Players by Revenue
3.1.1 Global Top Fragment-based Drug Discovery Players by Revenue (2016-2021)
3.1.2 Global Fragment-based Drug Discovery Revenue Market Share by Players (2016-2021)
3.2 Global Fragment-based Drug Discovery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Fragment-based Drug Discovery Revenue
3.4 Global Fragment-based Drug Discovery Market Concentration Ratio
3.4.1 Global Fragment-based Drug Discovery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fragment-based Drug Discovery Revenue in 2020
3.5 Fragment-based Drug Discovery Key Players Head office and Area Served
3.6 Key Players Fragment-based Drug Discovery Product Solution and Service
3.7 Date of Enter into Fragment-based Drug Discovery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Fragment-based Drug Discovery Breakdown Data by Type
4.1 Global Fragment-based Drug Discovery Historic Market Size by Type (2016-2021)
4.2 Global Fragment-based Drug Discovery Forecasted Market Size by Type (2022-2027)
5 Fragment-based Drug Discovery Breakdown Data by Application
5.1 Global Fragment-based Drug Discovery Historic Market Size by Application (2016-2021)
5.2 Global Fragment-based Drug Discovery Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Fragment-based Drug Discovery Market Size (2016-2027)
6.2 North America Fragment-based Drug Discovery Market Size by Type
6.2.1 North America Fragment-based Drug Discovery Market Size by Type (2016-2021)
6.2.2 North America Fragment-based Drug Discovery Market Size by Type (2022-2027)
6.2.3 North America Fragment-based Drug Discovery Market Size by Type (2016-2027)
6.3 North America Fragment-based Drug Discovery Market Size by Application
6.3.1 North America Fragment-based Drug Discovery Market Size by Application (2016-2021)
6.3.2 North America Fragment-based Drug Discovery Market Size by Application (2022-2027)
6.3.3 North America Fragment-based Drug Discovery Market Size by Application (2016-2027)
6.4 North America Fragment-based Drug Discovery Market Size by Country
6.4.1 North America Fragment-based Drug Discovery Market Size by Country (2016-2021)
6.4.2 North America Fragment-based Drug Discovery Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Fragment-based Drug Discovery Market Size (2016-2027)
7.2 Europe Fragment-based Drug Discovery Market Size by Type
7.2.1 Europe Fragment-based Drug Discovery Market Size by Type (2016-2021)
7.2.2 Europe Fragment-based Drug Discovery Market Size by Type (2022-2027)
7.2.3 Europe Fragment-based Drug Discovery Market Size by Type (2016-2027)
7.3 Europe Fragment-based Drug Discovery Market Size by Application
7.3.1 Europe Fragment-based Drug Discovery Market Size by Application (2016-2021)
7.3.2 Europe Fragment-based Drug Discovery Market Size by Application (2022-2027)
7.3.3 Europe Fragment-based Drug Discovery Market Size by Application (2016-2027)
7.4 Europe Fragment-based Drug Discovery Market Size by Country
7.4.1 Europe Fragment-based Drug Discovery Market Size by Country (2016-2021)
7.4.2 Europe Fragment-based Drug Discovery Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Fragment-based Drug Discovery Market Size (2016-2027)
8.2 Asia-Pacific Fragment-based Drug Discovery Market Size by Type
8.2.1 Asia-Pacific Fragment-based Drug Discovery Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Fragment-based Drug Discovery Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Fragment-based Drug Discovery Market Size by Type (2016-2027)
8.3 Asia-Pacific Fragment-based Drug Discovery Market Size by Application
8.3.1 Asia-Pacific Fragment-based Drug Discovery Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Fragment-based Drug Discovery Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Fragment-based Drug Discovery Market Size by Application (2016-2027)
8.4 Asia-Pacific Fragment-based Drug Discovery Market Size by Region
8.4.1 Asia-Pacific Fragment-based Drug Discovery Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Fragment-based Drug Discovery Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Fragment-based Drug Discovery Market Size (2016-2027)
9.2 Latin America Fragment-based Drug Discovery Market Size by Type
9.2.1 Latin America Fragment-based Drug Discovery Market Size by Type (2016-2021)
9.2.2 Latin America Fragment-based Drug Discovery Market Size by Type (2022-2027)
9.2.3 Latin America Fragment-based Drug Discovery Market Size by Type (2016-2027)
9.3 Latin America Fragment-based Drug Discovery Market Size by Application
9.3.1 Latin America Fragment-based Drug Discovery Market Size by Application (2016-2021)
9.3.2 Latin America Fragment-based Drug Discovery Market Size by Application (2022-2027)
9.3.3 Latin America Fragment-based Drug Discovery Market Size by Application (2016-2027)
9.4 Latin America Fragment-based Drug Discovery Market Size by Country
9.4.1 Latin America Fragment-based Drug Discovery Market Size by Country (2016-2021)
9.4.2 Latin America Fragment-based Drug Discovery Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Fragment-based Drug Discovery Market Size (2016-2027)
10.2 Middle East & Africa Fragment-based Drug Discovery Market Size by Type
10.2.1 Middle East & Africa Fragment-based Drug Discovery Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Fragment-based Drug Discovery Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Fragment-based Drug Discovery Market Size by Type (2016-2027)
10.3 Middle East & Africa Fragment-based Drug Discovery Market Size by Application
10.3.1 Middle East & Africa Fragment-based Drug Discovery Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Fragment-based Drug Discovery Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Fragment-based Drug Discovery Market Size by Application (2016-2027)
10.4 Middle East & Africa Fragment-based Drug Discovery Market Size by Country
10.4.1 Middle East & Africa Fragment-based Drug Discovery Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Fragment-based Drug Discovery Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Astex Pharmaceuticals
11.1.1 Astex Pharmaceuticals Company Details
11.1.2 Astex Pharmaceuticals Business Overview
11.1.3 Astex Pharmaceuticals Fragment-based Drug Discovery Introduction
11.1.4 Astex Pharmaceuticals Revenue in Fragment-based Drug Discovery Business (2016-2021)
11.1.5 Astex Pharmaceuticals Recent Development
11.2 Alveus Pharmaceuticals
11.2.1 Alveus Pharmaceuticals Company Details
11.2.2 Alveus Pharmaceuticals Business Overview
11.2.3 Alveus Pharmaceuticals Fragment-based Drug Discovery Introduction
11.2.4 Alveus Pharmaceuticals Revenue in Fragment-based Drug Discovery Business (2016-2021)
11.2.5 Alveus Pharmaceuticals Recent Development
11.3 Beactica
11.3.1 Beactica Company Details
11.3.2 Beactica Business Overview
11.3.3 Beactica Fragment-based Drug Discovery Introduction
11.3.4 Beactica Revenue in Fragment-based Drug Discovery Business (2016-2021)
11.3.5 Beactica Recent Development
11.4 Charles River Laboratories
11.4.1 Charles River Laboratories Company Details
11.4.2 Charles River Laboratories Business Overview
11.4.3 Charles River Laboratories Fragment-based Drug Discovery Introduction
11.4.4 Charles River Laboratories Revenue in Fragment-based Drug Discovery Business (2016-2021)
11.4.5 Charles River Laboratories Recent Development
11.5 Crown Bioscience
11.5.1 Crown Bioscience Company Details
11.5.2 Crown Bioscience Business Overview
11.5.3 Crown Bioscience Fragment-based Drug Discovery Introduction
11.5.4 Crown Bioscience Revenue in Fragment-based Drug Discovery Business (2016-2021)
11.5.5 Crown Bioscience Recent Development
11.6 Emerald BioStructures
11.6.1 Emerald BioStructures Company Details
11.6.2 Emerald BioStructures Business Overview
11.6.3 Emerald BioStructures Fragment-based Drug Discovery Introduction
11.6.4 Emerald BioStructures Revenue in Fragment-based Drug Discovery Business (2016-2021)
11.6.5 Emerald BioStructures Recent Development
11.7 Evotec
11.7.1 Evotec Company Details
11.7.2 Evotec Business Overview
11.7.3 Evotec Fragment-based Drug Discovery Introduction
11.7.4 Evotec Revenue in Fragment-based Drug Discovery Business (2016-2021)
11.7.5 Evotec Recent Development
11.8 Kinetic Discovery
11.8.1 Kinetic Discovery Company Details
11.8.2 Kinetic Discovery Business Overview
11.8.3 Kinetic Discovery Fragment-based Drug Discovery Introduction
11.8.4 Kinetic Discovery Revenue in Fragment-based Drug Discovery Business (2016-2021)
11.8.5 Kinetic Discovery Recent Development
11.9 Proteros Fragments
11.9.1 Proteros Fragments Company Details
11.9.2 Proteros Fragments Business Overview
11.9.3 Proteros Fragments Fragment-based Drug Discovery Introduction
11.9.4 Proteros Fragments Revenue in Fragment-based Drug Discovery Business (2016-2021)
11.9.5 Proteros Fragments Recent Development
11.10 Sprint Bioscience
11.10.1 Sprint Bioscience Company Details
11.10.2 Sprint Bioscience Business Overview
11.10.3 Sprint Bioscience Fragment-based Drug Discovery Introduction
11.10.4 Sprint Bioscience Revenue in Fragment-based Drug Discovery Business (2016-2021)
11.10.5 Sprint Bioscience Recent Development
11.11 Structure Based Design
11.11.1 Structure Based Design Company Details
11.11.2 Structure Based Design Business Overview
11.11.3 Structure Based Design Fragment-based Drug Discovery Introduction
11.11.4 Structure Based Design Revenue in Fragment-based Drug Discovery Business (2016-2021)
11.11.5 Structure Based Design Recent Development
11.12 Sygnature Discovery
11.12.1 Sygnature Discovery Company Details
11.12.2 Sygnature Discovery Business Overview
11.12.3 Sygnature Discovery Fragment-based Drug Discovery Introduction
11.12.4 Sygnature Discovery Revenue in Fragment-based Drug Discovery Business (2016-2021)
11.12.5 Sygnature Discovery Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Fragment-based Drug Discovery Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Fragment Screening
Table 3. Key Players of Fragment Optimization
Table 4. Global Fragment-based Drug Discovery Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Fragment-based Drug Discovery Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Fragment-based Drug Discovery Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Fragment-based Drug Discovery Market Share by Regions (2016-2021)
Table 8. Global Fragment-based Drug Discovery Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Fragment-based Drug Discovery Market Share by Regions (2022-2027)
Table 10. Fragment-based Drug Discovery Market Trends
Table 11. Fragment-based Drug Discovery Market Drivers
Table 12. Fragment-based Drug Discovery Market Challenges
Table 13. Fragment-based Drug Discovery Market Restraints
Table 14. Global Fragment-based Drug Discovery Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Fragment-based Drug Discovery Market Share by Players (2016-2021)
Table 16. Global Top Fragment-based Drug Discovery Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fragment-based Drug Discovery as of 2020)
Table 17. Ranking of Global Top Fragment-based Drug Discovery Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Fragment-based Drug Discovery Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Fragment-based Drug Discovery Product Solution and Service
Table 21. Date of Enter into Fragment-based Drug Discovery Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Fragment-based Drug Discovery Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Fragment-based Drug Discovery Revenue Market Share by Type (2016-2021)
Table 25. Global Fragment-based Drug Discovery Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Fragment-based Drug Discovery Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Fragment-based Drug Discovery Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Fragment-based Drug Discovery Revenue Market Share by Application (2016-2021)
Table 29. Global Fragment-based Drug Discovery Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Fragment-based Drug Discovery Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Fragment-based Drug Discovery Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Fragment-based Drug Discovery Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Fragment-based Drug Discovery Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Fragment-based Drug Discovery Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Fragment-based Drug Discovery Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Fragment-based Drug Discovery Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Fragment-based Drug Discovery Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Fragment-based Drug Discovery Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Fragment-based Drug Discovery Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Fragment-based Drug Discovery Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Fragment-based Drug Discovery Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Fragment-based Drug Discovery Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Fragment-based Drug Discovery Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Fragment-based Drug Discovery Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Fragment-based Drug Discovery Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Fragment-based Drug Discovery Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Fragment-based Drug Discovery Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Fragment-based Drug Discovery Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Fragment-based Drug Discovery Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Fragment-based Drug Discovery Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Fragment-based Drug Discovery Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Fragment-based Drug Discovery Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Fragment-based Drug Discovery Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Fragment-based Drug Discovery Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Fragment-based Drug Discovery Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Fragment-based Drug Discovery Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Fragment-based Drug Discovery Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Fragment-based Drug Discovery Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Fragment-based Drug Discovery Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Fragment-based Drug Discovery Market Size by Country (2022-2027) & (US$ Million)
Table 61. Astex Pharmaceuticals Company Details
Table 62. Astex Pharmaceuticals Business Overview
Table 63. Astex Pharmaceuticals Fragment-based Drug Discovery Product
Table 64. Astex Pharmaceuticals Revenue in Fragment-based Drug Discovery Business (2016-2021) & (US$ Million)
Table 65. Astex Pharmaceuticals Recent Development
Table 66. Alveus Pharmaceuticals Company Details
Table 67. Alveus Pharmaceuticals Business Overview
Table 68. Alveus Pharmaceuticals Fragment-based Drug Discovery Product
Table 69. Alveus Pharmaceuticals Revenue in Fragment-based Drug Discovery Business (2016-2021) & (US$ Million)
Table 70. Alveus Pharmaceuticals Recent Development
Table 71. Beactica Company Details
Table 72. Beactica Business Overview
Table 73. Beactica Fragment-based Drug Discovery Product
Table 74. Beactica Revenue in Fragment-based Drug Discovery Business (2016-2021) & (US$ Million)
Table 75. Beactica Recent Development
Table 76. Charles River Laboratories Company Details
Table 77. Charles River Laboratories Business Overview
Table 78. Charles River Laboratories Fragment-based Drug Discovery Product
Table 79. Charles River Laboratories Revenue in Fragment-based Drug Discovery Business (2016-2021) & (US$ Million)
Table 80. Charles River Laboratories Recent Development
Table 81. Crown Bioscience Company Details
Table 82. Crown Bioscience Business Overview
Table 83. Crown Bioscience Fragment-based Drug Discovery Product
Table 84. Crown Bioscience Revenue in Fragment-based Drug Discovery Business (2016-2021) & (US$ Million)
Table 85. Crown Bioscience Recent Development
Table 86. Emerald BioStructures Company Details
Table 87. Emerald BioStructures Business Overview
Table 88. Emerald BioStructures Fragment-based Drug Discovery Product
Table 89. Emerald BioStructures Revenue in Fragment-based Drug Discovery Business (2016-2021) & (US$ Million)
Table 90. Emerald BioStructures Recent Development
Table 91. Evotec Company Details
Table 92. Evotec Business Overview
Table 93. Evotec Fragment-based Drug Discovery Product
Table 94. Evotec Revenue in Fragment-based Drug Discovery Business (2016-2021) & (US$ Million)
Table 95. Evotec Recent Development
Table 96. Kinetic Discovery Company Details
Table 97. Kinetic Discovery Business Overview
Table 98. Kinetic Discovery Revenue in Fragment-based Drug Discovery Business (2016-2021) & (US$ Million)
Table 99. Kinetic Discovery Recent Development
Table 100. Proteros Fragments Company Details
Table 101. Proteros Fragments Business Overview
Table 102. Proteros Fragments Fragment-based Drug Discovery Product
Table 103. Proteros Fragments Revenue in Fragment-based Drug Discovery Business (2016-2021) & (US$ Million)
Table 104. Proteros Fragments Recent Development
Table 105. Sprint Bioscience Company Details
Table 106. Sprint Bioscience Business Overview
Table 107. Sprint Bioscience Fragment-based Drug Discovery Product
Table 108. Sprint Bioscience Revenue in Fragment-based Drug Discovery Business (2016-2021) & (US$ Million)
Table 109. Sprint Bioscience Recent Development
Table 110. Structure Based Design Company Details
Table 111. Structure Based Design Business Overview
Table 112. Structure Based Design Fragment-based Drug Discovery Product
Table 113. Structure Based Design Revenue in Fragment-based Drug Discovery Business (2016-2021) & (US$ Million)
Table 114. Structure Based Design Recent Development
Table 115. Sygnature Discovery Company Details
Table 116. Sygnature Discovery Business Overview
Table 117. Sygnature Discovery Fragment-based Drug Discovery Product
Table 118. Sygnature Discovery Revenue in Fragment-based Drug Discovery Business (2016-2021) & (US$ Million)
Table 119. Sygnature Discovery Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Fragment-based Drug Discovery Market Share by Type: 2020 VS 2027
Figure 2. Fragment Screening Features
Figure 3. Fragment Optimization Features
Figure 4. Global Fragment-based Drug Discovery Market Share by Application: 2020 VS 2027
Figure 5. Academic and Research Institutions Case Studies
Figure 6. Biopharmaceutical Companies Case Studies
Figure 7. Contract Research Organizations (CROs) Case Studies
Figure 8. Fragment-based Drug Discovery Report Years Considered
Figure 9. Global Fragment-based Drug Discovery Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Fragment-based Drug Discovery Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Fragment-based Drug Discovery Market Share by Regions: 2020 VS 2027
Figure 12. Global Fragment-based Drug Discovery Market Share by Regions (2022-2027)
Figure 13. Global Fragment-based Drug Discovery Market Share by Players in 2020
Figure 14. Global Top Fragment-based Drug Discovery Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fragment-based Drug Discovery as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Fragment-based Drug Discovery Revenue in 2020
Figure 16. Global Fragment-based Drug Discovery Revenue Market Share by Type (2016-2021)
Figure 17. Global Fragment-based Drug Discovery Revenue Market Share by Type (2022-2027)
Figure 18. North America Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Fragment-based Drug Discovery Market Share by Type (2016-2027)
Figure 20. North America Fragment-based Drug Discovery Market Share by Application (2016-2027)
Figure 21. North America Fragment-based Drug Discovery Market Share by Country (2016-2027)
Figure 22. United States Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Fragment-based Drug Discovery Market Share by Type (2016-2027)
Figure 26. Europe Fragment-based Drug Discovery Market Share by Application (2016-2027)
Figure 27. Europe Fragment-based Drug Discovery Market Share by Country (2016-2027)
Figure 28. Germany Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Fragment-based Drug Discovery Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Fragment-based Drug Discovery Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Fragment-based Drug Discovery Market Share by Region (2016-2027)
Figure 38. China Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Fragment-based Drug Discovery Market Share by Type (2016-2027)
Figure 46. Latin America Fragment-based Drug Discovery Market Share by Application (2016-2027)
Figure 47. Latin America Fragment-based Drug Discovery Market Share by Country (2016-2027)
Figure 48. Mexico Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Fragment-based Drug Discovery Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Fragment-based Drug Discovery Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Fragment-based Drug Discovery Market Share by Country (2016-2027)
Figure 54. Turkey Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Fragment-based Drug Discovery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Astex Pharmaceuticals Revenue Growth Rate in Fragment-based Drug Discovery Business (2016-2021)
Figure 58. Alveus Pharmaceuticals Revenue Growth Rate in Fragment-based Drug Discovery Business (2016-2021)
Figure 59. Beactica Revenue Growth Rate in Fragment-based Drug Discovery Business (2016-2021)
Figure 60. Charles River Laboratories Revenue Growth Rate in Fragment-based Drug Discovery Business (2016-2021)
Figure 61. Crown Bioscience Revenue Growth Rate in Fragment-based Drug Discovery Business (2016-2021)
Figure 62. Emerald BioStructures Revenue Growth Rate in Fragment-based Drug Discovery Business (2016-2021)
Figure 63. Evotec Revenue Growth Rate in Fragment-based Drug Discovery Business (2016-2021)
Figure 64. Kinetic Discovery Revenue Growth Rate in Fragment-based Drug Discovery Business (2016-2021)
Figure 65. Proteros Fragments Revenue Growth Rate in Fragment-based Drug Discovery Business (2016-2021)
Figure 66. Sprint Bioscience Revenue Growth Rate in Fragment-based Drug Discovery Business (2016-2021)
Figure 67. Structure Based Design Revenue Growth Rate in Fragment-based Drug Discovery Business (2016-2021)
Figure 68. Sygnature Discovery Revenue Growth Rate in Fragment-based Drug Discovery Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed